Gene Editing Emerges From the Lab
Gene Editing Emerges From the Lab Editas, CRISPR Therapeutics and Intellia blast out of long consolidations as prominent tech fund manager argues their efforts to cure disease will outpace Tesla in public value Author: Dec 22, 2020 Editas, CRISPR Therapeutics and Intellia blast out of long consolidations as prominent tech fund manager argues their efforts to cure disease will outpace Tesla in public value (Veteran tech columnist Jon Markman publishes Strategic Advantage, a guide to investing in the great digital transformation of business and society. Click here for a two-week trial.) Editas ...